Literature DB >> 12970676

Subcellular localisation of Cdc25A determines cell fate.

C Leisser1, G Rosenberger, S Maier, G Fuhrmann, M Grusch, S Strasser, S Huettenbrenner, S Fassl, D Polgar, S Krieger, C Cerni, R Hofer-Warbinek, R deMartin, G Krupitza.   

Abstract

Cell division cycle 25A (Cdc25A) was shown to colocalise both with nuclear and cytoplasmic proteins. Recently, we have demonstrated that overexpressed Cdc25A promoted the survival of rat 423 cells through indirect activation of PKB-protein kinase B. Using a Cdc25A:ER fusion protein, which can be shuttled from the cytoplasm into the nucleus, the present investigation evidences that the antiapoptotic effect of Cdc25A was restricted to its cytoplasmic localisation in rat 423 cells. In contrast, nuclear Cdc25A overexpression caused dephosphorylation and nuclear retention of the proapoptotic transcription factor Forkhead in rhabdomyosarcoma-like 1 (FKHRL1) in human N.1 ovarian carcinoma cells. This resulted in the increased constitutive expression of the FKHRL1 targets Fas ligand and Bim, and promoted apoptosis. Thus, the Cdc25A oncogene, which was found to be frequently overexpressed in certain human cancers, can increase or decrease the susceptibility to apoptosis depending on the cell-type-specific subcellular distribution.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 12970676     DOI: 10.1038/sj.cdd.4401318

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  7 in total

1.  Transforming growth factor beta facilitates beta-TrCP-mediated degradation of Cdc25A in a Smad3-dependent manner.

Authors:  Dipankar Ray; Yasuhisa Terao; Dipali Nimbalkar; Li-Hao Chu; Maddalena Donzelli; Tateki Tsutsui; Xianghong Zou; Asish K Ghosh; John Varga; Giulio F Draetta; Hiroaki Kiyokawa
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

Review 2.  The role of Cdc25A in the regulation of cell proliferation and apoptosis.

Authors:  Tao Shen; Shile Huang
Journal:  Anticancer Agents Med Chem       Date:  2012-07       Impact factor: 2.505

3.  Cdc25A-driven proliferation regulates CD62L levels and lymphocyte movement in response to interleukin-7.

Authors:  Christina Kittipatarin; Wenqing Li; Scott K Durum; Annette R Khaled
Journal:  Exp Hematol       Date:  2010-09-08       Impact factor: 3.084

4.  Accelerated elimination of ultraviolet-induced DNA damage through apoptosis in CDC25A-deficient skin.

Authors:  Jodi Yanagida; Brianna Hammiller; Jenan Al-Matouq; Michaela Behrens; Carol S Trempus; Susan K Repertinger; Laura A Hansen
Journal:  Carcinogenesis       Date:  2012-07-04       Impact factor: 4.944

5.  CRISPR-Cas knockout of miR21 reduces glioma growth.

Authors:  Lisa Nieland; Thomas S van Solinge; Pike See Cheah; Liza M Morsett; Joseph El Khoury; Joseph I Rissman; Benjamin P Kleinstiver; Marike L D Broekman; Xandra O Breakefield; Erik R Abels
Journal:  Mol Ther Oncolytics       Date:  2022-04-06       Impact factor: 6.311

6.  Loss of cytoplasmic CDK1 predicts poor survival in human lung cancer and confers chemotherapeutic resistance.

Authors:  Chunyu Zhang; Abdel G Elkahloun; Matthew Robertson; Joell J Gills; Junji Tsurutani; Joanna H Shih; Junya Fukuoka; M Christine Hollander; Curtis C Harris; William D Travis; Jin Jen; Phillip A Dennis
Journal:  PLoS One       Date:  2011-08-24       Impact factor: 3.240

7.  Targeting 14-3-3ε-CDC25A interactions to trigger apoptotic cell death in skin cancer.

Authors:  Thomas R Holmes; Jenan Al-Matouq; Matti Holmes; Lauren Nicola; Justin C Rudd; Sándor Lovas; Laura A Hansen
Journal:  Oncotarget       Date:  2020-09-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.